Literature DB >> 16847903

Role of laparoscopy in the management of adrenal malignancies.

Celestino Pio Lombardi1, Marco Raffaelli, Carmela De Crea, Rocco Bellantone.   

Abstract

BACKGROUND AND OBJECTIVES: The role of laparoscopic approach for the treatment of malignant adrenal diseases is still controversial. The aim of this study was to verify the results of laparoscopic adrenalectomy (LA) in the management of adrenal malignancies.
METHODS: The medical records of all the patients who underwent laparoscopic procedures for adrenal diseases and in whom malignancy was demonstrated at final histology were reviewed.
RESULTS: Nine patients were included (three malignant pheochromocytomas, four adrenocortical carcinomas, and two adrenal metastases). At a mean follow-up of 23.0 months, all but two patients were alive. One patient died for metastatic disease and the other one for unrelated causes. One patient operated on for an adrenocortical carcinoma developed a pelvic recurrence. One patient operated on for a malignant pheochromocytoma developed multiple intra-abdominal recurrences. No other case of recurrence was observed.
CONCLUSIONS: The results of this study demonstrate that LA can have a role also in case of adrenal malignancies. Conversion to open surgery is mandatory in case of local invasion and when the dissection cannot be as accurate as in conventional operations. A preliminary laparoscopic exploration can be planned in case of suspected malignant lesions to confirm the diagnosis and to evaluate their operability. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16847903     DOI: 10.1002/jso.20599

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  Retroperitoneoscopic adrenalectomy: tips and tricks.

Authors:  Carmela De Crea; Marco Raffaelli; Gerardo D'Amato; Pietro Princi; Pierpaolo Gallucci; Rocco Bellantone; Celestino Pio Lombardi
Journal:  Updates Surg       Date:  2017-06-13

Review 2.  Laparoscopic adrenalectomy.

Authors:  Marco Raffaelli; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2019-07

Review 3.  Adrenocortical carcinoma: which surgical approach?

Authors:  Bruno Carnaille
Journal:  Langenbecks Arch Surg       Date:  2011-09-27       Impact factor: 3.445

4.  Adrenocortical carcinoma surgery-surgical extent and approach.

Authors:  C Vanbrugghe; A J Lowery; C Golffier; D Taieb; F Sebag
Journal:  Langenbecks Arch Surg       Date:  2016-07-13       Impact factor: 3.445

5.  Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?

Authors:  F Porpiglia; C Fiori; F C Daffara; B Zaggia; A Ardito; R M Scarpa; M Papotti; A Berruti; G V Scagliotti; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-12-22       Impact factor: 4.256

Review 6.  Current and emerging therapies for advanced adrenocortical carcinoma.

Authors:  Lyndal J Tacon; Ruth S Prichard; Patsy S H Soon; Bruce G Robinson; Roderick J Clifton-Bligh; Stan B Sidhu
Journal:  Oncologist       Date:  2011-01-06

7.  Primary small cell neuroendocrine carcinoma of adrenal gland.

Authors:  Kosuke Ogawa; Yousuke Shimizu; Shoko Uketa; Noriaki Utsunomiya; Kazutaka Kida; Misa Ishihara; Kimio Hashimoto; Sojun Kanamaru
Journal:  Int Cancer Conf J       Date:  2019-03-27

8.  Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm?

Authors:  Giovanni Ramacciato; Paolo Mercantini; Marco La Torre; Fabrizio Di Benedetto; Giorgio Ercolani; Matteo Ravaioli; Micaela Piccoli; Gianluigi Melotti
Journal:  Surg Endosc       Date:  2007-08-18       Impact factor: 4.584

9.  Castleman's disease - an unusual indication for laparoscopic adrenalectomy.

Authors:  Maciej Otto; Lukasz Wieprzowski; Jacek Dzwonkowski; Bogna Ziarkiewicz-Wróblewska
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2011-11-08       Impact factor: 1.195

10.  Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art.

Authors:  Amir H Lebastchi; John W Kunstman; Tobias Carling
Journal:  J Oncol       Date:  2012-10-18       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.